
Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.
Featured post
Aligning Clinical Trial Design with Investment Priorities
When working with investors, it’s critical that drug and device developers consider how their clinical trial design aligns with investment priorities. Natalia Muehlemann and Ari Brettman (Blackstone Life Sciences) discuss what investors look for when evaluating clinical development programs, and the value of simulation-guided design in informing decisions and facilitating communication with investors.

Clear Filters
Filter by

February 17, 2022
It is a common perception that the role of a Data Manager is only to perform what we call “Data Cleaning”; making sure...
Read article